Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00184028 · ClinicalTrials.gov registry record · Phase 2
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck
A Phase 2 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00184028 is a Phase 2 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 12 participants.
The verdict
NCT00184028, a Phase 2 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
This research study is for subjects with squamous cell cancer of the head and neck which is not solely treatable with surgery or radiation. This research study involves treatment with an experimental chemotherapy combination of oxaliplatin and Taxotere. Tha main purpose of this study is to assess the effectiveness of this combination of medications for this type of cancer. Approximately 54 subjects will take part in this study.
Interventions
- DRUG Oxaliplatin
- DRUG Taxotere
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00184028
The ClinicalTrials.gov registry entry for NCT00184028 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxaliplatin is the first listed.
NCT00184028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00184028 about?
NCT00184028 is a clinical study titled "Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck". This research study is for subjects with squamous cell cancer of the head and neck which is not solely treatable with surgery or radiation. This research study involves treatment with an experimental chemotherapy combination of oxaliplatin and Taxotere. Tha main purpose of this study is to assess th...
What is the current status of trial NCT00184028?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2004-09. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00184028?
The interventions under investigation include: Oxaliplatin (DRUG), Taxotere (DRUG).
Who is sponsoring clinical trial NCT00184028?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.